Stay informed of research news regarding our thought leaders, collaborations, and partnerships.
Manesh Patel, MD, officially begins his term as president of the American Heart Association on July 1, stepping into one of the most visible volunteer leadership roles in cardiovascular health with a perspective shaped by decades of expe
New findings from a large, real-world study offer reassuring evidence: the Pfizer-BioNTech COVID-19 vaccine continues to demonstrate a strong and consistent safety profile years after individuals received their first vaccine.Recently published in the journal Respiratory Medicine, “Long-term safety of the Pfizer-BioNTech COVID-19 vaccine: Results from the HERO-together study” highlights data and analysis from HERO-Together, a patient-centered research initiative designed to examine potential side effects and hospitalizations reported by participants after receiving a COVID-19 vaccine.
DCRI Accomplishments showcases the publications, awards, and other achievements of our faculty members. Each quarter, a new collection will highlight the most recent accomplishments. During Spring 2026, DCRI faculty members were appointed to leadership roles in influential scientific and medical organizations, and received prestigious awards and notable promotions.
The Duke Clinical Research Institute (DCRI) and CardioVascular Clinical Trialists (CVCT) have announced a formal three-year partnership to establish a clear pathway to regulatory and clinical acceptance of cardiovascular prevention therapies. Titled "Pathway to Prevention," the initiative will unite stakeholders from academia, industry, government, nonprofits, and the technology sector to develop practical guidance to advance prevention indications.
